| Revista: | Revista brasileira de psiquiatria |
| Base de datos: | PERIÓDICA |
| Número de sistema: | 000279923 |
| ISSN: | 1516-4446 |
| Autores: | Soares, Claudio N1 Almeida, Osvaldo P2 |
| Instituciones: | 1Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts. Estados Unidos de América 2University of Western Australia, Department of Psychiatry, Nedlands, Australia Occidental. Australia |
| Año: | 2000 |
| Periodo: | Ene-Mar |
| Volumen: | 22 |
| Número: | 1 |
| Paginación: | 17-21 |
| País: | Brasil |
| Idioma: | Portugués |
| Tipo de documento: | Artículo |
| Enfoque: | Experimental, caso clínico |
| Resumen en inglés | OBJECTIVES: Previous studies suggest that the perimenopause is a period of increased risk for physical and emotional disturbances. The intense fluctuation in hormone levels during the perimenopause has been associated with the presence of depressive symptoms. The present study investigated the association between levels of estradiol (E2) and follicle-stimulating hormone (FSH) and the severity of depressive symptoms of women in the perimenopause. METHODS: Fifty perimenopausal women (age: 40-55 years, all meeting DSM-IV criteria for depressive disorders [major depressive disorder, dysthymia or depressive disorders NOS], with irregular periods and FSH levels FSH>20 UI/L) were selected from a larger sample of patients attending specialized gynecologic (n=101) and psychiatric (n=75) outpatient services. They were randomized to receive treatment with patches of placebo or 17 b-estradiol for 12 weeks. Serum levels of estradiol and FSH, and scores on the Montgomery-Åsberg Depression Scale (MADRS) were used as outcome measures. RESULTS: There was a significant correlation between changes in MADRS scores and changes in FSH (r de Pearson=0.554, p<0.001) and E2 levels (r=0.436, p=0.003) among patients treated with placebo or E2. Conclusions: These preliminary results show a significant association between hormone levels and changes in depression scores. They also suggest that changes in hormone levels play an important role in the pathogenesis and/or treatment of depression in the perimenopause. The results of large community-based cohort studies should clarify the importance of the association between hormonal fluctuation and depressive symptoms during the perimenopause |
| Resumen en portugués | variabilidade hormonal no surgimento/exacerbação dos transtornos depressivos na perimenopausa |
| Disciplinas: | Medicina |
| Palabras clave: | Endocrinología, Ginecología y obstetricia, Psiquiatría, Terapia hormonal, Depresión, Estradiol, FSH, Perimenopausia, Climaterio, Estrógenos |
| Keyword: | Medicine, Endocrinology, Gynecology and obstetrics, Psychiatry, Hormonal therapy, Depression, Estradiol, Climacteric, Perimenopause, FSH, Estrogens |
| Texto completo: | Texto completo (Ver HTML) |
